Cyclo[Gly-3-hydroxy*-2-methyl-1-oxoundecyl-N-methyl-L-Leu-L-aIle-L-Ser-L-aThr-]
|
|
Cyclo[Gly-3-hydroxy*-2-methyl-1-oxoundecyl-N-methyl-L-Leu-L-aIle-L-Ser-L-aThr-] Eigenschaften
- Schmelzpunkt:
- 100-102 °C
- Siedepunkt:
- 994.0±65.0 °C(Predicted)
- Dichte
- 1.051±0.06 g/cm3(Predicted)
- pka
- 12.79±0.70(Predicted)
Sicherheit
Cyclo[Gly-3-hydroxy*-2-methyl-1-oxoundecyl-N-methyl-L-Leu-L-aIle-L-Ser-L-aThr-] Chemische Eigenschaften,Einsatz,Produktion Methoden
Cyclo[Gly-3-hydroxy*-2-methyl-1-oxoundecyl-N-methyl-L-Leu-L-aIle-L-Ser-L-aThr-] Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Cyclo[Gly-3-hydroxy*-2-methyl-1-oxoundecyl-N-methyl-L-Leu-L-aIle-L-Ser-L-aThr-] Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 0)Lieferanten
| Firmenname | Telefon | Land | Produktkatalog | Edge Rate |
|---|
- Antibiotic SF-1902A5
- Cyclo[Gly-3-hydroxy*-2-methyl-1-oxoundecyl-N-methyl-L-Leu-L-aIle-L-Ser-L-aThr-]
- SF-1902A5
- (3R)-N-[(3R)-1-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-amino-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxybutanoyl]amino]-3-formyl-5-methyl-2-oxohexan-3-yl]-3-hydroxy-N-methyl-2-methylideneundecanamide
- Cyclo[L-alloisoleucyl-L-seryl-L-allothreonylglycyl-(2R,3R)-3-hydroxy-2-methylundecanoyl-N-methyl-L-leucyl]
- 69639-47-0
- C34H61N5O9




